IVDR entered into application on 26 May 2022

The new In Vitro Diagnostic Medical Devices Regulation (EU) 2017/746 (IVDR) entered into application on 26 May 2022. The new regulation will...

2022. május 31.
Hírek, Termék hírek
Investment company Ferd will come as a co-owner of Aidian together with Nordstjernan

We are happy to announce that the Norwegian family-owned investment company Ferd will come as a co-owner of Aidian together with Nordstjerna...

2022. május 2.
Hírek
Flu activity is increasing in the Northern hemisphere

Viruses are major causes of upper respiratory tract infections (URTIs). Yet, antibiotics are commonly prescribed for URTIs. Even if, the flu...

2022. április 28.
Hírek, Termék hírek
New Sustainability web page and Communication on Progress report published

We have updated our website with a new sustainability section. You can now find more information about sustainability at Aidian, our commitm...

2022. április 26.
Hírek
Aidian's portfolio grows in East-Central Europe with point of care systems LabPad® and LabPad® Evolution

LabPad and LabPad Evolution systems from Biosynex are now available through Aidian offices in the Czech Republic, Slovakia and Hungary. Lab...

2022. április 12.
Hírek, Termék hírek
CRP might aid in assessment of the severity and improvement of type 2 diabetes mellitus in COVID-19

Emerging evidence show that among patients with COVID-19, the risk of death of diabetes is 50% higher than those without diabetes, especiall...

2022. március 29.
Hírek, Termék hírek, COVID-19
Meridian Revogene® – the platform built to grow with you

Aidian is a proud distributor of the Meridian's flexible fully automated molecular PCR platform Revogene® that is capable of both single ana...

2022. március 24.
Hírek, Termék hírek
QuikRead go iFOBT showed good diagnostic accuracy for colorectal cancer

Non-invasive point of care (POC) faecal immunochemical tests (FITs) aid in triaging both asymptomatic and symptomatic patients for colonosco...

2022. március 16.
Hírek, Termék hírek